May 31, 2025

Featuring perspectives from Dr Natalie S Callander and Dr Thomas Martin, including the following topics:

• Introduction (0:00)
• Current and Emerging Therapeutic Approaches for Multiple Myeloma — Dr Callander (4:42)
• CAR T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates — Dr Martin (31:16)

CME...

May 30, 2025

Featuring perspectives from Dr Farshid Dayyani, Ms Caroline Kuhlman, Dr Philip A Philip and Ms Amanda K Wagner, including the following topics:

• Introduction: Initial Management of Pancreatic Adenocarcinoma (PAD) (0:00)
• Clinical Presentation and Prognosis of PAD; Recent Advances in Up-Front Treatment for Metastatic PAD...

May 29, 2025

Featuring an interview with Dr Rafael Fonseca, including the following topics:

• Safe management of bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for patients with multiple myeloma (MM) (0:00)
• Sequencing bispecific antibodies and CAR T-cell therapy (10:40)
• Available data with and potential...

May 29, 2025

Featuring a slide presentation and related discussion from Dr Rafael Fonseca, including the following topics:

• Recent updates from ASH 2024 on the up-front use of anti-CD38 monoclonal antibodies for multiple myeloma (MM) (0:00)
• Updated data with belantamab mafodotin for the management of MM (12:39)
• Updated findings with...

May 27, 2025

Featuring an interview with Dr Rinath M Jesselsohn, including the following topics:

• Evaluating first-line treatment of metastatic ER-positive, HER2-positive breast cancer: heredERA Breast Cancer study (0:00)
  • Kuemmel S et al. heredERA Breast Cancer: A phase III, randomized, open-label study evaluating the efficacy...